Qualigen Therapeutics Inc.

NASDAQ: QLGN
Share price (10/3/25): $5.23
Market cap (10/3/25): $8.867 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from S-1 8 pages Placement Agency Agreement

from S-1/A 8 pages Placement Agency Agreement

from S-1/A 8 pages Placement Agency Agreement

from S-1/A 8 pages Placement Agency Agreement

from 8-K 52 pages Underwriting Agreement Between Ritter Pharmaceuticals, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Ritter Pharmaceuticals, Inc. Underwriting Agreement

from S-1/A 52 pages Underwriting Agreement Between Ritter Pharmaceuticals, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Ritter Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 44 pages Underwriting Agreement Between Ritter Pharmaceuticals, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Ritter Pharmaceuticals, Inc. Underwriting Agreement

from S-1/A 62 pages Underwriting Agreement Between Ritter Pharmaceuticals, Inc. and Aegis Capital Corp., as Representative of the Several Underwriters Ritter Pharmaceuticals, Inc. Underwriting Agreement